Factors That Predict the Growth of Residual Nonfunctional Pituitary Adenomas: Correlations between Relapse and Cell Cycle Markers

Table 1

Overview of the clinical and histopathological characteristics of patients with adenoma progression. indicates residual adenoma size as measured at the largest diameter.

Patient	Sex	Age	Residual adenoma size, mm	Time to residual adenoma progression, years	p21 expression	p27 expression	p53 expression	Ki-67 expression
1	F	63	13	3.6	10	75	5	5
2	F	55	23	6.1	5	90	2	5
3	M	67	29	5.5	15	90	3	10
4	M	33	33	4.2	40	90	2	5
5	M	61	28	1	30	90	15	10
6	M	54	12	5.9	10	90	2	3
7	F	29	11	5.2	2	75	2	4
8	F	45	22	1.5	5	90	0	2
9	M	44	6	4	15	75	1	3
10	F	56	15	1.5	30	90	10	8
11	M	29	18	6	0	75	5	3
12	F	53	5	4.8	5	90	0	1
13	F	40	11	3.8	10	90	2	1
14	F	59	19	4.7	2	90	0	3
15	M	23	25	2.4	0	90	2	2
16	M	32	18	3.9	0	75	0	6
17	M	49	6	2.6	10	90	3	10